Worldwide consumer demand driven by rises in living standards is generating new and emerging human toxicity concerns. From added microplastics and other substances classed as persistent, bioaccumulative and toxic, there is increasing scrutiny on the safety of your chemical. Our toxicology staff has a long and distinguished heritage in toxicology assessment. For more than 50 years, we've performed approximately 1,500 toxicology studies annually, such as QSAR modelling for in silico assessments and complex multigeneration in vivo DART studies. This has allowed us to amass insight, knowledge and wisdom which, by partnering with us, you can benefit from. State-of-the-art infrastructure, including market-leading inhalation and infusion capabilities ensure the delivery of reliable and robust human toxicology data.